BNP PARIBAS FINANCIAL MARKETS - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 55 filers reported holding CLEARSIDE BIOMEDICAL INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q3 2023$184
-22.4%
2120.0%0.00%
Q2 2023$237
+11750.0%
212
+10500.0%
0.00%
Q1 2023$2
-99.8%
2
-99.8%
0.00%
Q4 2022$1,067
-99.9%
953
-39.6%
0.00%
Q3 2022$1,782,000
-91.2%
1,577
-88.5%
0.00%
Q2 2022$20,157,000
-39.8%
13,712
-6.2%
0.00%
Q1 2022$33,487,000
-16.7%
14,6230.0%0.00%
Q4 2021$40,213,000
+670116.7%
14,623
+1462200.0%
0.00%
Q3 2021$6,000
+20.0%
10.0%0.00%
Q2 2021$5,000
+150.0%
10.0%0.00%
Q1 2021$2,000
-90.9%
1
-87.5%
0.00%
Q4 2020$22,000
+83.3%
80.0%0.00%
Q3 2020$12,000
-20.0%
80.0%0.00%
Q2 2020$15,000
-84.8%
8
-86.2%
0.00%
Q1 2020$99,000
-41.1%
580.0%0.00%
Q4 2019$168,000
-91.5%
58
-98.2%
0.00%
Q3 2019$1,981,000
-35.2%
3,1440.0%0.00%
Q2 2019$3,055,000
-63.6%
3,144
-48.3%
0.00%
Q1 2019$8,399,000
+1496.8%
6,086
+1137.0%
0.00%
Q4 2018$526,000
-90.6%
492
-46.1%
0.00%
Q3 2018$5,615,000
-42.5%
913
-0.1%
0.00%
Q2 2018$9,771,000
-79.5%
914
-79.4%
0.00%
Q1 2018$47,641,000
+60.9%
4,440
+5.0%
0.00%
Q4 2017$29,610,000
+69.9%
4,230
+112.1%
0.00%
Q3 2017$17,428,000
-9.5%
1,994
-5.7%
0.00%
Q2 2017$19,259,000
+3175.3%
2,114
+2756.8%
0.00%
Q1 2017$588,000
-38.6%
74
-30.8%
0.00%
Q4 2016$957,000
-81.3%
107
-63.7%
0.00%
Q3 2016$5,118,0002950.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q4 2022
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 169,629$147,5600.05%
BROWN WEALTH MANAGEMENT, LLC 110,000$95,6890.05%
Carmignac Gestion 2,132,744$1,855,2740.03%
WATER ISLAND CAPITAL LLC 82,500$720.01%
Northeast Financial Consultants Inc 83,000$72,2020.01%
XTX Topco Ltd 27,545$23,9610.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,600$152,7540.00%
Curi Wealth Management, LLC 25,000$21,7480.00%
Banque Cantonale Vaudoise 40,000$350.00%
SYNOVUS FINANCIAL CORP 58,071$50,5160.00%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders